<?xml version="1.0"?><rss version="2.0"><channel><title>pharmaceuticals_and_healthcare - Latest News</title><link>http://news.prlog.org/tag/pharmaceuticals-and-healthcare/</link><description>pharmaceuticals_and_healthcare - Latest News (Press Releases) - Read news before it's news</description><language>en-us</language><ttl>3600</ttl>
<item><title>PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013</title><link>http://www.prlog.org/12105356-pharmasphere-global-generics-strategy-key-drivers-markets-and-trends-in-2013.html</link><description>Multinationals Threatening Domestic Growth of India’s Generics Firms, Says GlobalData...</description></item>
<item><title>EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022</title><link>http://www.prlog.org/12100603-epicast-report-cystic-fibrosis-epidemiology-forecast-to-2022.html</link><description>National healthcare practices affect the diagnosis rate and survival rate of any disease, and CF patients can sometimes experience substantially different lives depending on the country they are born and treated in, states a new report by research and...</description></item>
<item><title>EpiCast Report: Pediatric Respiratory Syncytial Virus Infections and Prophylactics Populations</title><link>http://www.prlog.org/12096787-epicast-report-pediatric-respiratory-syncytial-virus-infections-and-prophylactics-populations.html</link><description>Respiratory syncytial virus (RSV) infections account for a significant portion of healthcare resources consumed across the US, as the health of vulnerable infants is seriously threatened by the common winter ailment, states a new report by GlobalData.</description></item>
<item><title>PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022</title><link>http://www.prlog.org/12096775-pharmapoint-osteoporosis-global-drug-forecast-and-market-analysis-to-2022.html</link><description>A major paradigm shift in late and mid-stage product development from anti-resorptive therapies to anabolic drugs will prove the key driver in the global osteoporosis market, states research and consulting firm GlobalData.</description></item>
<item><title>PharmaPoint: Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2022</title><link>http://www.prlog.org/12096043-pharmapoint-multiple-sclerosis-global-drug-forecast-and-market-analysis-to-2022.html</link><description>Established players are investing heavily to maintain their presence in the increasingly competitive Multiple Sclerosis (MS) therapy market, states a new report by GlobalData.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – New Zealand</title><link>http://www.prlog.org/12091263-healthcare-regulatory-and-reimbursement-landscape-new-zealand.html</link><description>PHARMAC Holding Back New Zealand Healthcare Industry Growth, Says GlobalData Report</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Thailand</title><link>http://www.prlog.org/12088171-healthcare-regulatory-and-reimbursement-landscape-thailand.html</link><description>This report provides information on the healthcare, regulatory, and reimbursement landscape of Thailand, and gives an overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Colombia</title><link>http://www.prlog.org/12087379-healthcare-regulatory-and-reimbursement-landscape-colombia.html</link><description>Colombia and the US Improve Trade Relations, Opening Opportunities for both Healthcare Markets</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Egypt</title><link>http://www.prlog.org/12087368-healthcare-regulatory-and-reimbursement-landscape-egypt.html</link><description>This report provides an overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers.</description></item>
<item><title>PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report</title><link>http://www.prlog.org/12087268-pharmaleaders-innovative-mid-cap-biotechnology-benchmark-report.html</link><description>Regeneron Named GlobalData’s Innovative Mid-Cap Biotech Benchmark Leader due to Eylea Territory Expansions</description></item>
<item><title>EpiCast Report: Human Immunodeficiency Virus - Epidemiology Forecast to 2022</title><link>http://www.prlog.org/12073593-epicast-report-human-immunodeficiency-virus-epidemiology-forecast-to-2022.html</link><description>his report provides an overview of the risk factors and global trends of HIV in seven major markets</description></item>
<item><title>Cytomegalovirus (CMV) Infections - Analysis and Market Forecasts to 2019</title><link>http://www.prlog.org/12073444-cytomegalovirus-cmv-infections-analysis-and-market-forecasts-to-2019.html</link><description>ENDSInfections Threaten the Immunosuppressed, but Cytomegalovirus Treatments Due to Improve</description></item>
<item><title>EpiCast Report: Epilepsy - Epidemiology Forecast to 2022</title><link>http://www.prlog.org/12071387-epicast-report-epilepsy-epidemiology-forecast-to-2022.html</link><description>This report provides an overview of risk factors and global trends for epilepsy in the seven major markets</description></item>
<item><title>EpiCast: Osteoporosis Epidemiology Forecast to 2022</title><link>http://www.prlog.org/12071378-epicast-osteoporosis-epidemiology-forecast-to-2022.html</link><description>This report provides an overview of the risk factors and global trends of osteoporosis in seven major markets</description></item>
<item><title>EpiCast Report: Seasonal Influenza Vaccines - Epidemiology Forecast to 2022</title><link>http://www.prlog.org/12055098-epicast-report-seasonal-influenza-vaccines-epidemiology-forecast-to-2022.html</link><description>US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic spike, predicts business intelligence provider GlobalData.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape - South Africa</title><link>http://www.prlog.org/12055056-healthcare-regulatory-and-reimbursement-landscape-south-africa.html</link><description>South Africa Healthcare Market to Grow, but Reform Implementation Necessary</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Morocco</title><link>http://www.prlog.org/12044342-healthcare-regulatory-and-reimbursement-landscape-morocco.html</link><description>It provides valuable insights on the trends and segmentation of the pharmaceutical market.</description></item>
<item><title>PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis</title><link>http://www.prlog.org/12040772-pharmapoint-prostate-cancer-global-drug-forecast-and-market-analysis.html</link><description>This report provides comprehensive information on prostate cancer therapeutics, highlighting the treatment guidelines and identifying and analyzing key trends shaping the market</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Netherlands</title><link>http://www.prlog.org/12040731-healthcare-regulatory-and-reimbursement-landscape-netherlands.html</link><description>This report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Turkey</title><link>http://www.prlog.org/12040617-healthcare-regulatory-and-reimbursement-landscape-turkey.html</link><description>The report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.</description></item>
<item><title>PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis</title><link>http://www.prlog.org/12031339-pharmapoint-seasonal-influenza-vaccines-global-drug-forecast-and-market-analysis.html</link><description>This report provides detailed information on the global seasonal influenza market.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia</title><link>http://www.prlog.org/12029201-healthcare-regulatory-and-reimbursement-landscape-saudi-arabia.html</link><description>This report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure.</description></item>
<item><title>Biotech Strategy 2012 - Licensing, Collaboration, and M&amp;A Trends</title><link>http://www.prlog.org/12029193-biotech-strategy-2012-licensing-collaboration-and-ma-trends.html</link><description>The report also shows an increasing trend for pharmaceutical companies to expand their businesses into emerging markets such as China, Brazil, and India</description></item>
<item><title>Hyperparathyroidism – Analysis and Market Forecasts to 2019</title><link>http://www.prlog.org/12017828-hyperparathyroidism-analysis-and-market-forecasts-to-2019.html</link><description>New Report Forecasts Hyperparathyroidism Therapeutics Market at $2.62 Billion by 2019</description></item>
<item><title>Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018</title><link>http://www.prlog.org/11944721-endometriosis-therapeutics-pipeline-assessment-and-market-forecasts-to-2018.html</link><description>Endometriosis Therapeutics Market is Forecast to Show Steady Growth Until 2018</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Spain</title><link>http://www.prlog.org/11945739-healthcare-regulatory-and-reimbursement-landscape-spain.html</link><description>The Increasing Elderly Population and the High Unemployment Rate are Challenges for the Government of Spain</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape- Germany</title><link>http://www.prlog.org/11945651-healthcare-regulatory-and-reimbursement-landscape-germany.html</link><description>The Rising Elderly Population and it’s Associated Disease Burden Add to the Economic Challenges Faced by the German Government</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape Italy</title><link>http://www.prlog.org/11944568-healthcare-regulatory-and-reimbursement-landscape-italy.html</link><description>Rising Elderly Population and Associated Disease Burden Adds to the Economic Challenges Facing the Italian Government</description></item>
<item><title>Global Markets Direct: Gout Therapeutics - Pipeline Assessment and Market Forecasts to 2019</title><link>http://www.prlog.org/11937144-global-markets-direct-gout-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html</link><description>New Gout Treatments May Get Toes Tapping and provides analysis of a number of key areas.</description></item>
<item><title>Global Markets Direct: Home Healthcare Market (Equipment, Service &amp; Telehealth/ Telemedicine)</title><link>http://www.prlog.org/11935586-global-markets-direct-home-healthcare-market-equipment-service-telehealth-telemedicine.html</link><description>Global Markets Direct is a global market intelligence services company providing information research and analysis products and services.</description></item>
<item><title>Cefozopran - Comprehensive patent search</title><link>http://www.prlog.org/11842211-cefozopran-comprehensive-patent-search.html</link><description>Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.</description></item>
<item><title>Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020</title><link>http://www.prlog.org/11840191-cisplatin-cervical-cancer-analysis-and-forecasts-to-2020.html</link><description>&quot;Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020” provides Cisplatin sales estimates for US, EU5 and Japan.</description></item>
<item><title>Cardiovascular Partnering Terms and Agreements</title><link>http://www.prlog.org/11831264-cardiovascular-partnering-terms-and-agreements.html</link><description>The Cardiovascular Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.</description></item>
<item><title>Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US</title><link>http://www.prlog.org/11743069-emerging-market-for-clinical-trials-in-poland-cost-advantages-of-nearly-30-as-compared-to-the-us.html</link><description>The report provides a comprehensive insight of the reasons for outsourcing clinical trials to Poland and the key services provided by the Clinical Research Organizations (CROs) of Poland.</description></item>
<item><title>Healthcare, Regulatory and Reimbursement Landscape – Singapore</title><link>http://www.prlog.org/11739404-healthcare-regulatory-and-reimbursement-landscape-singapore.html</link><description>The report provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Singapore.</description></item>
<item><title>Axitinib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020</title><link>http://www.prlog.org/11725427-axitinib-renal-cell-carcinoma-analysis-and-forecasts-to-2020.html</link><description>The report provides detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020).</description></item>
<item><title>Dermatology Therapeutics Market to 2017 - Alopecia market is Forecast to Decline</title><link>http://www.prlog.org/11721296-dermatology-therapeutics-market-to-2017-alopecia-market-is-forecast-to-decline.html</link><description>The report provides an in-depth analysis of the major dermatology diseases including Herpes Zoster, Herpes Simplex, Psoriasis, Alopecia, Rosacea, Atopic Dermatitis and Acne.</description></item>
<item><title>Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title><link>http://www.prlog.org/11714718-non-small-cell-lung-cancer-nsclc-therapeutics-pipeline-assessment-and-market-forecasts-to-2018.html</link><description>The report provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.</description></item>
<item><title>Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11553216-immtech-pharmaceuticals-inc-immp-financial-and-strategic-analysis-review.html</link><description>. It is engaged in the discovery and development of therapies for the treatment of infectious diseases such as bacterial, viral, and fungal infections, including hepatitis C and hospital-acquired infections.</description></item>
<item><title>Advocate Health Care - Strategic Analysis Review</title><link>http://www.prlog.org/11511484-advocate-health-care-strategic-analysis-review.html</link><description>Advocate Health Care (Advocate Health) is an integrated health care network organization providing healthcare services</description></item>
<item><title>Adventist Health System - Strategic Analysis Review</title><link>http://www.prlog.org/11511445-adventist-health-system-strategic-analysis-review.html</link><description>Adventist Health System (AHS) is a Protestant medical health care organization serving through hospitals, nursing facilities and home care agencies</description></item>
<item><title>Acusphere, Inc. (ACUS) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11511434-acusphere-inc-acus-financial-and-strategic-analysis-review.html</link><description>Acusphere, Inc. (Acusphere) is a specialty pharmaceutical company engaged in the development of novel drugs as well as making changes in the existing formulations by making the use of its proprietary microsphere technology</description></item>
<item><title>ViroPharma Incorporated (VPHM) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11511401-viropharma-incorporated-vphm-financial-and-strategic-analysis-review.html</link><description>ViroPharma Incorporated (ViroPharma) is a biopharmaceutical company. It is principally engaged in developing and marketing pharmaceutical products for infectious diseases</description></item>
<item><title>Community Health Systems, Inc. (CYH) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11511263-community-health-systems-inc-cyh-financial-and-strategic-analysis-review.html</link><description>Community Health Systems, Inc. (CHS) is an operator of hospitals in the United States</description></item>
<item><title>Catholic Health Initiatives - Strategic Analysis Review</title><link>http://www.prlog.org/11511237-catholic-health-initiatives-strategic-analysis-review.html</link><description>Catholic Health Initiatives (CHI) is a non-profit organization that offers healthcare services in various states across the US.</description></item>
<item><title>Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11509043-pharmaceutical-product-development-inc-ppdi-financial-and-strategic-analysis-review.html</link><description>Global Markets Direct has added a new report Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic Analysis Review to its market research offerings.</description></item>
<item><title>Five Star Quality Care, Inc (FVE) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11508862-five-star-quality-care-inc-fve-financial-and-strategic-analysis-review.html</link><description>It provides inpatient hospitals plus associated satellite clinics namely New England Rehabilitation Hospital and Braintree Rehabilitation Hospital, which provide high-end services for a broad spectrum of acute care rehabilitation needs</description></item>
<item><title>Dong-A Pharmaceutical Co., Ltd. (000640) - Financial and Strategic Analysis Review</title><link>http://www.prlog.org/11508821-dong-pharmaceutical-co-ltd-000640-financial-and-strategic-analysis-review.html</link><description>Provides You an in-depth strategic analysis of the company’s businesses and operations.</description></item></channel></rss>